Postoperative Nausea and Vomiting in Paediatric Anaesthesia

Ivan Urits, Vwaire Orhurhu, Mark R Jones, Leena Adamian, Matthew Borchart, Annemarie Galasso, Omar Viswanath, Ivan Urits, Vwaire Orhurhu, Mark R Jones, Leena Adamian, Matthew Borchart, Annemarie Galasso, Omar Viswanath

Abstract

Postoperative nausea and vomiting (PONV) is a common complication in paediatric anaesthesia and is a source of significant morbidity. Various independent risk factors have been implicated in the development of paediatric PONV, including higher pain scores postoperatively, the use of opioids for pain management and the use of volatile anaesthetics for the maintenance of anaesthesia. This review of the current literature regarding the prevention and treatment of paediatric PONV is based on a search of the PubMed database, which identified published clinical trials, systematic reviews and meta-analyses. While the occurrence of PONV in many cases is difficult to avoid entirely, the risk can be mitigated by the use of multimodal nonopioid analgesic regimens, total intravenous drugs in favour of volatile anaesthetics and an appropriate regimen of prophylactic pharmacotherapy. Frequently administered drug classes for the prevention of PONV include corticosteroids, 5HT3 antagonists and anticholinergics. The clinical use of the findings in the literature may help to reduce the occurrence of PONV in children. In this review, we provide comprehensive and updated information on the risk factors contributing the occurrence of PONV in children, outline the current opinion on the drugs that are commonly used for management and provide an overview of the guidelines that are used to help establish the prophylaxis and treatment of paediatric PONV.

Keywords: Anaesthesia; guidelines for prophylaxis and treatment; postoperative nausea and vomiting; risk factors.

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare.

© Copyright 2020 by Turkish Anaesthesiology and Intensive Care Society.

References

    1. Eberhart LHJ, Morin AM, Guber D, Kretz FJ, Schäuffelen A, Treiber H, et al. Applicability of risk scores for postoperative nausea and vomiting in adults to paediatric patients. Br J Anaesth. 2004;93:386–92. doi: 10.1093/bja/aeh221.
    1. Edler AA, Mariano ER, Golianu B, Kuan C, Pentcheva K. An analysis of factors influencing postanesthesia recovery after pediatric ambulatory tonsillectomy and adenoidectomy. Anesth Analg. 2007;104:784–9. doi: 10.1213/01.ane.0000258771.53068.09.
    1. Brown EG, Anderson JE, Burgess D, Bold RJ, Farmer DL. Pediatric surgical readmissions: Are they truly preventable? J Pediatr Surg. 2017;52:161–5. doi: 10.1016/j.jpedsurg.2016.10.037.
    1. Eberhart LHJ, Geldner G, Kranke P, Morin AM, Schäuffelen A, Treiber H, et al. The Development and Validation of a Risk Score to Predict the Probability of Postoperative Vomiting in Pediatric Patients. Anesth Analg. 2004;99:1630–7. doi: 10.1213/01.ANE.0000135639.57715.6C.
    1. Apfel CC, Philip BK, Cakmakkaya OS, Shilling A, Shi YY, Leslie JB, et al. Who is at risk for postdischarge nausea and vomiting after ambulatory surgery? Anesthesiology. 2012;117:475–86. doi: 10.1097/ALN.0b013e318267ef31.
    1. Minai F, Shafiq F, Rehman A. Audit of postoperative nausea and vomiting in paediatric day case surgery. J Pak Med Assoc. 2011;61:273–6.
    1. Bourdaud N, Devys JM, Bientz J, Lejus C, Hebrard A, Tirel O, et al. Development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients: the VPOP score. Paediatr Anaesth. 2014;24:945–52. doi: 10.1111/pan.12428.
    1. Gan TJJ, Diemunsch P, Habib ASSS, Kovac A, Kranke P, Meyer TAAA, et al. Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg. 2014;118:85–113. doi: 10.1213/ANE.0000000000000002.
    1. Schaefer MS, Kranke P, Weibel S, Kreysing R, Ochel J, Kienbaum P. Total intravenous anesthesia vs single pharmacological prophylaxis to prevent postoperative vomiting in children: A systematic review and meta-analysis. Pediatr Anesth. 2017;27:1202–9. doi: 10.1111/pan.13268.
    1. Naja Z, Kanawati S, Al Khatib R, Ziade F, Naja ZZ, Naja AS, et al. The effect of IV dexamethasone versus local anesthetic infiltration technique in postoperative nausea and vomiting after tonsillectomy in children: A randomized double-blind clinical trial. Int J Pediatr Otorhinolaryngol. 2017;92:21–6. doi: 10.1016/j.ijporl.2016.10.030.
    1. Roberts GW, Bekker TB, Carlsen HH, Moffatt CH, Slattery PJ, McClure F. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in dose-related a manner. Anesth Analg. 2005;101:1343–8. doi: 10.1213/.
    1. Faasse MA, Lindgren BW, Frainey BT, Marcus CR, Szczodry DM, Glaser AP, et al. Perioperative effects of caudal and transversus abdominis plane (TAP) blocks for children undergoing urologic robot-assisted laparoscopic surgery. J Pediatr Urol. 2015;11:121.e1–121.e7. doi: 10.1016/j.jpurol.2014.10.010.
    1. Dorkham MC, Chalkiadis GA, Von Ungern Sternberg BS, Davidson AJ. Effective postoperative pain management in children after ambulatory surgery, with a focus on tonsillectomy: Barriers and possible solutions. Paediatr Anaesth. 2014;24:239–48. doi: 10.1111/pan.12327.
    1. Klemetti S, Kinnunen I, Suominen T, Antila H, Vahlberg T, Grenman R, et al. The effect of preoperative fasting on postoperative pain, nausea and vomiting in pediatric ambulatory tonsillectomy. Int J Pediatr Otorhinolaryngol. 2009;73:263–73. doi: 10.1016/j.ijporl.2008.10.014.
    1. Tudor-Drobjewski BA, Marhofer P, Kimberger O, Huber WD, Roth G, Triffterer L. Randomised controlled trial comparing preoperative carbohydrate loading with standard fasting in paediatric anaesthesia. Br J Anaesth. 2018;121:656–61. doi: 10.1016/j.bja.2018.04.040.
    1. Ashok V, Bala I, Bharti N, Jain D, Samujh R. Effects of intraoperative liberal fluid therapy on postoperative nausea and vomiting in children-A randomized controlled trial. Paediatr Anaesth. 2017;27:810–5. doi: 10.1111/pan.13179.
    1. Ho CM, Wu HL, Ho ST, Wang JJ. Dexamethasone prevents postoperative nausea and vomiting: Benefit versus risk. Acta Anaesthesiol Taiwanica. 2011;49:100–4. doi: 10.1016/j.aat.2011.06.002.
    1. Awad K, Ahmed H, Abushouk AI, Al Nahrawi S, Elsherbeny MY, Mustafa SM, et al. Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis. Int J Surg. 2016;36:152–63. doi: 10.1016/j.ijsu.2016.10.034.
    1. Sayed JAF, Riad MAM, Ali MO. Comparison of dexamethasone or intravenous fluids or combination of both on postoperative nausea, vomiting and pain in pediatric strabismus surgery. J Clin Anesth. 2016;34:136–42. doi: 10.1016/j.jclinane.2016.03.049.
    1. Thomas R, Jones N. Prospective randomized, double-blind comparative study of dexamethasone, ondansetron, and ondansetron plus dexamethasone as prophylactic antiemetic therapy in patients undergoing day-case gynaecological surgery. Br J Anaesth. 2001;87:588–92. doi: 10.1093/bja/87.4.588.
    1. Kizilcik N, Bilgen S, Menda F, Türe H, Aydın B, Kaspar EC, et al. Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients. Aesthetic Plast Surg. 2017;41:204–10. doi: 10.1007/s00266-016-0772-0.
    1. Yiu Y, Mahida JB, Cooper JN, Elsey NM, Deans KJ, Minneci PC, et al. The effect of perioperative dexamethasone dosing on post-tonsillectomy hemorrhage risk. Int J Pediatr Otorhinolaryngol. 2017;98:19–24. doi: 10.1016/j.ijporl.2017.04.033.
    1. Mahant S, Keren R, Localio R, Luan X, Song L, Shah SS, et al. Dexamethasone and Risk of Bleeding in Children Undergoing Tonsillectomy. Otolaryngol Neck Surg. 2014;150:872–9. doi: 10.1177/0194599814521555.
    1. Qi D, Pulinilkunnil T, An D, Ghosh S, Abrahani A, Pospisilik JA, et al. Single-dose dexamethasone induces whole-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism. Diabetes. 2004;53:1790–7. doi: 10.2337/diabetes.53.7.1790.
    1. Colin B, Gan TJ. Cancer Recurrence and Hyperglycemia with Dexamethasone for Postoperative Nausea and Vomiting Prophylaxis. Anesth Analg. 2014;118:1154–6. doi: 10.1213/ANE.0000000000000223.
    1. Chanimov M, Koren-Michowitz M, Cohen ML, Pilipodi S, Bahar M. Tumor lysis syndrome induced by dexamethasone. Anesthesiology. 2006;105:633–4. doi: 10.1097/00000542-200609000-00042.
    1. Bartlett R, Hartle AJ. Routine use of dexamethasone for postoperative nausea and vomiting: the case against. Anaesthesia. 2013;68:892–6. doi: 10.1111/anae.12309.
    1. Thompson AJ, Lummis SCR. The 5-HT3 receptor as a therapeutic target. Expert Opin Ther Targets. 2007;11:527–40. doi: 10.1517/14728222.11.4.527.
    1. Paech MJ, Rucklidge MWM, Banks SL, Gurrin LC, Orlikowski CEP, Pavy TJG. The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron. Anaesth Intensive Care. 2003;31:11–7. doi: 10.1177/0310057X0303100102.
    1. White PF, Tang J, Hamza MA, Ogunnaike B, Lo M, Wender RH, et al. The Use of Oral Granisetron Versus Intravenous Ondansetron for Antiemetic Prophylaxis in Patients Undergoing Laparoscopic Surgery: The Effect on Emetic Symptoms and Quality of Recovery. Anesth Analg. 2006;102:1387–93. doi: 10.1213/.
    1. Birmingham SD, Mecklenburg BW, Lujan E, Dacanay RG, Boyle PK, Green R. Dolasetron versus ondansetron as single-agent prophylaxis for patients at increased risk for postoperative nausea and vomiting: a prospective, double-blind, randomized trial. Mil Med. 2006;171:913–6. doi: 10.7205/MILMED.171.9.913.
    1. Fujii Y. The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy. Curr Pharm Des. 2005;11:3173–83. doi: 10.2174/1381612054864911.
    1. Pinarli FG, Elli M, Dagdemir A, Baysal K, Acar S. Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer. Pediatr Blood Cancer. 2006;47:567–71. doi: 10.1002/pbc.20639.
    1. Buyukavci M, Olgun H, Ceviz N. The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia. Am J Clin Oncol. 2005;28:201–4. doi: 10.1097/01.coc.0000144849.41300.0a.
    1. Tricco AC, Blondal E, Veroniki AA, Soobiah C, Vafaei A, Ivory J, et al. Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis. BMC Med. 2016;14:216. doi: 10.1186/s12916-016-0761-9.
    1. Keefe DL. The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern? Oncologist. 2002;7:65–72. doi: 10.1634/theoncologist.7-1-65.
    1. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, et al. A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting. N Engl J Med. 2004;350:2441–51. doi: 10.1056/NEJMoa032196.
    1. Henzi I, Sonderegger J, Tramèr MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anesth Can d’anesthésie. 2000;47:537–51. doi: 10.1007/BF03018945.
    1. Bourdaud N, François C, Jacqmarcq O, Guye ML, Jean J, Studer C, et al. Addition of droperidol to prophylactic ondansetron and dexamethasone in children at high risk for postoperative vomiting. A randomized, controlled, double-blind study. Br J Anaesth. 2017;118:918–23. doi: 10.1093/bja/aex099.
    1. Flubacher P, Fournier N, Cherpillod J, Waridel F, Nydegger M, Albrecht E. A randomised controlled trial of placebo, droperidol or ondansetron to prevent nausea and vomiting after tonsillectomy in children receiving dexamethasone. Anaesthesia. 2017;72:859–63. doi: 10.1111/anae.13907.
    1. Mt-Isa S, Tomlin S, Sutcliffe A, Underwood M, Williamson P, Croft NM, et al. Prokinetics Prescribing in Paediatrics. J Pediatr Gastroenterol Nutr. 2015;60:508–14. doi: 10.1097/MPG.0000000000000657.
    1. Lau Moon Lin M, Robinson PD, Flank J, Sung L, Dupuis LL. The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis. Drug Saf. 2016;39:675–87. doi: 10.1007/s40264-016-0418-9.
    1. Apfel CC, Zhang K, George E, Shi S, Jalota L, Hornuss C, et al. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: A systematic review and meta-analysis. Clin Ther. 2010;32:1987–2002. doi: 10.1016/j.clinthera.2010.11.014.
    1. Spinks A, Wasiak J. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2011:CD002851. doi: 10.1002/14651858.CD002851.pub4.
    1. Enarson P, Gouin S, Goldman RD. Dimenhydrinate use for children with vomiting. Can Fam Physician. 2011;57:431–2.
    1. Kranke P, Diemunsch P. The 2014 consensus guidelines for the management of postoperative nausea and vomiting A leapfrog towards a postoperative nausea and vomiting-free hospital. Eur J Anaesthesiol. 2014;31:651–3. doi: 10.1097/EJA.0000000000000080.
    1. Blacoe DA, Cunning E, Bell G. Paediatric day-case surgery: an audit of unplanned hospital admission Royal Hospital for Sick Children, Glasgow. Anaesthesia. 2008;63:610–5. doi: 10.1111/j.1365-2044.2008.05438.x.
    1. Hooper VD. SAMBA Consensus Guidelines for the Management of Postoperative Nausea and Vomiting: An Executive Summary for Perianesthesia Nurses. 2015.
    1. Gan TJ, Sinha AC, Kovac AL, Jones RK, Cohen SA, Battikha JP, et al. A Randomized, Double-Blind, Multicenter Trial Comparing Transdermal Scopolamine Plus Ondansetron to Ondansetron Alone for the Prevention of Postoperative Nausea and Vomiting in the Outpatient Setting. Anesth Analg. 2009;108:1498–504. doi: 10.1213/ane.0b013e31819e431f.
    1. Höhne C. Postoperative nausea and vomiting in pediatric anesthesia. Curr Opin Anaesthesiol. 2014;27:303–8. doi: 10.1097/ACO.0000000000000073.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi